Cargando…
TET2 regulates immune tolerance in chronically activated mast cells
Mutation of the TET2 DNA-hydroxymethylase has been associated with a number of immune pathologies. The disparity in phenotype and clinical presentation among these pathologies leads to questions regarding the role of TET2 mutation in promoting disease evolution in different immune cell types. Here w...
Autores principales: | Rigo, Riccardo, Chelbi, Rabie, Agopian, Julie, Letard, Sebastien, Griffon, Aurélien, Ghamlouch, Hussein, Vernerey, Julien, Ladopoulos, Vasileios, Voisset, Edwige, De Sepulveda, Paulo, Guittard, Geoffrey, Nunès, Jacques A., Bidaut, Ghislain, Göttgens, Berthold, Weber, Michael, Bernard, Olivier A., Dubreuil, Patrice, Soucie, Erinn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057605/ https://www.ncbi.nlm.nih.gov/pubmed/35393954 http://dx.doi.org/10.1172/jci.insight.154191 |
Ejemplares similares
-
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
por: Damaj, Gandhi, et al.
Publicado: (2014) -
SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
por: Voisset, Edwige, et al.
Publicado: (2020) -
An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia
por: Lopez, Sophie, et al.
Publicado: (2016) -
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
por: Dubreuil, Patrice, et al.
Publicado: (2009) -
TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis
por: Rosikiewicz, Wojciech, et al.
Publicado: (2020)